| Autor: |
Konstantinos Kalogeras, Richard J. Jabbour, Radoslaw Pracon, Tito Kabir, Joanne Shannon, Alison Duncan, Cesare Quarto, Ee‐Ling Heng, Hazim Rahbi, Evangelos Oikonomou, Efstratios Katsianos, Niket Patel, Navin Chandra, Michael‐Andrew Vavuranakis, Suzane Cadiz, Maria Bougiakli, Robert D. Smith, Gerasimos Siasos, Manolis Vavuranakis, Simon Davies, Miles Dalby, Vasileios Panoulas |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 11 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2047-9980 |
| DOI: |
10.1161/JAHA.122.028038 |
| Popis: |
Background No data currently exist comparing the contemporary iterations of balloon‐expandable (BE) Edwards SAPIEN 3/Ultra and the self‐expanding (SE) Medtronic Evolut PRO/R34 valves. The aim of the study was the comparison of these transcatheter heart valves with emphasis on patients with small aortic annulus. Methods and Results In this retrospective registry, periprocedural outcomes and midterm all‐cause mortality were analyzed. A total of 1673 patients (917 SE versus 756 BE) were followed up for a median of 15 months. A total of 194 patients died (11.6%) during follow‐up. SE and BE groups showed similar survival at 1 (92.6% versus 90.6%) and 3 (80.3% versus 85.2%) years (Plog‐rank=0.136). Compared with the BE group, patients treated with the SE device had lower peak (16.3±8 mm Hg SE versus 21.9±8 mm Hg BE) and mean (8.8±5 mm Hg SE versus 11.5±5 mm Hg BE) gradients at discharge. Conversely, the BE group demonstrated lower rates of at least moderate paravalvular regurgitation postoperatively (5.6% versus 0.7% for SE and BE valves, respectively; P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text